IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination

被引:296
作者
Gran, B
Zhang, GX
Yu, S
Li, JF
Chen, XH
Ventura, ES
Kamoun, M
Rostami, A
机构
[1] Univ Penn, Med Ctr, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.169.12.7104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Experimental autoimmune encephalomyelitis (EAE) serves as a model for multiple sclerosis and is considered a CD4(+), Th1 cell-mediated autoimmune disease. IL-12 is a heterodimeric cytokine, composed of a p40 and a p35 subunit, which is thought to play an important role in the development of Th1 cells and can exacerbate EAE. We induced EAE with myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 (MOG(35-55)) in C57BL/6 mice and found that while IL-12p40-deficient (-/-) mice are resistant to EAE, IL-12p35(-/-) mice are susceptible. Typical spinal cord mononuclear cell infiltration and demyelination were observed in wild-type and IL-12p35(-/-) mice, whereas IL-12p40(-/-) mice had normal spinal cords. A Th1-type response to MOG(35-55) was observed in the draining lymph node and the spleen of wild-type mice. A weaker MOG(35-55)-specific Th1 response was observed in IL-12p35(-/-) mice, with lower production of IFN-gamma. By contrast, a Th2-type response to MOG(35-55) correlated with disease resistance in IL-12p40(-/-) mice. Production of TNF-alpha by microglia, CNS-infiltrating macrophages, and CD4(+) T cells was detected in wild-type and IL-12p35(-/-), but not in IL-12p40(-/-), mice. In addition, NO production was higher in IL-12p35(-/-) and wild-type mice than in IL-12p40(-/-) mice. These data demonstrate a redundancy of the IL-12 system in the induction of EAE and suggest that p40-related heterodimers, such as the recently cloned IL-23 (p40p19), may play an important role in disease pathogenesis.
引用
收藏
页码:7104 / 7110
页数:7
相关论文
共 48 条
[1]   Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells [J].
Aloisi, F ;
De Simone, R ;
Columba-Cabezas, S ;
Penna, G ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1705-1712
[2]   Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 [J].
Becher, B ;
Durell, BG ;
Noelle, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :493-497
[3]   T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen [J].
Benson, JM ;
Campbell, KA ;
Guan, Z ;
Gienapp, IE ;
Stuckman, SS ;
Forsthuber, T ;
Whitacre, CC .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) :1031-1038
[4]   Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice [J].
Calida, DM ;
Constantinescu, C ;
Purev, E ;
Zhang, GX ;
Ventura, ES ;
Lavi, E ;
Rostami, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :723-726
[5]  
Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO
[6]  
2-X
[7]   Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12:: A critical step in the differentiation of pathogenic autoreactive T cells [J].
Chang, JT ;
Shevach, EM ;
Segal, BM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :969-978
[8]   A semiquantitative assay for CD8(+) T-cell-mediated suppression of human immunodeficiency virus type 1 infection [J].
Chen, Y ;
Rinaldo, C ;
Gupta, P .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (01) :4-10
[9]   Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively [J].
Constantinescu, CS ;
Hilliard, B ;
Ventura, E ;
Wysocka, M ;
Showe, L ;
Lavi, E ;
Fujioka, T ;
Scott, P ;
Trinchieri, G ;
Rostami, A .
CLINICAL IMMUNOLOGY, 2001, 98 (01) :23-30
[10]  
Constantinescu CS, 1998, J IMMUNOL, V161, P5097